Kestra Medical shareholders elect 3 Class II directors, ratify PwC as auditor

KESTRA MEDICAL TECHNOLOGIES, LTD.

Annual meeting held Sept 9, 2026; 55.4M shares voted (94.53% of outstanding).
Raymond W. Cohen, Kevin Reilly, Traci S. Umberger elected as Class II directors to 2029 term.
Cohen received 37.3M for, 10.8M against; Reilly 38.9M for, 9.2M against; Umberger 38.9M for, 9.2M against.
PwC ratified as independent auditor for FY ending April 30, 2027 with 55.4M for, 8.5K against.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.